Unknown PHASE2 INTERVENTIONAL 2-arm NCT00882830

Electrical Muscle Stimulation (EMS), a Preventive and Therapeutic Tool for Critical Illness Polyneuromyopathy (CIPNM)

Electrical Muscle Stimulation (EMS), a Preventive and Therapeutic Tool for Critical Illness Polyneuromyopathy (CIPNM)- A Randomized Controlled Parallel Intervention Trial.

Sponsor: University of Athens

Conditions Critical Illness Polyneuromyopathy (CIPNM) ICU Acquired Weakness (ICUAW)

Interventions EMS

Updated 6 times since 2017 Last updated: Mar 12, 2015 Started: Sep 30, 2007 Primary completion: Jun 30, 2009 Completion: Sep 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00882830, this PHASE2 trial focuses on Critical Illness Polyneuromyopathy (CIPNM) and ICU Acquired Weakness (ICUAW) and remains ongoing. Sponsored by University of Athens, it has been updated 6 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
May 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

Status: Active Not Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — May 2017 [monthly]

Active Not Recruiting PHASE2

First recorded

Sep 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Athens

Data source: University of Athens

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Athens, Greece